Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,576 | 358 | 98.2% |
| Education | $99.99 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,066 | 78 | $0 (2024) |
| Lilly USA, LLC | $587.26 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $484.29 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $339.71 | 19 | $0 (2024) |
| PFIZER INC. | $326.31 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $277.51 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $275.38 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $227.06 | 12 | $0 (2024) |
| Corium, LLC | $212.78 | 9 | $0 (2024) |
| Novo Nordisk Inc | $208.69 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,789 | 105 | AstraZeneca Pharmaceuticals LP ($233.56) |
| 2023 | $1,656 | 104 | ABBVIE INC. ($271.97) |
| 2022 | $1,502 | 111 | ABBVIE INC. ($442.07) |
| 2021 | $728.96 | 39 | Astellas Pharma US Inc ($185.61) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Biological | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Endocrinology | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,427 | 3,027 | $324,592 | $116,319 |
| 2022 | 35 | 3,770 | 4,485 | $424,732 | $147,604 |
| 2021 | 32 | 2,979 | 3,585 | $309,613 | $120,105 |
| 2020 | 27 | 2,218 | 2,943 | $250,380 | $80,885 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 305 | 305 | $85,705 | $30,605 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 480 | $95,520 | $29,526 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 191 | $24,257 | $7,963 | 32.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 57 | 57 | $11,400 | $7,456 | 65.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 91 | 91 | $6,615 | $6,483 | 98.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 103 | 132 | $12,012 | $6,083 | 50.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 263 | 365 | $15,695 | $4,758 | 30.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 271 | 392 | $15,680 | $4,026 | 25.7% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 12 | 12 | $4,812 | $3,034 | 63.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 153 | 175 | $11,025 | $2,867 | 26.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 93 | 93 | $2,970 | $2,650 | 89.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 77 | 77 | $2,434 | $2,194 | 90.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $6,840 | $2,070 | 30.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 137 | 144 | $4,608 | $1,083 | 23.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 50 | 50 | $3,500 | $946.00 | 27.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 27 | 27 | $6,642 | $779.49 | 11.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 55 | 75 | $2,775 | $663.00 | 23.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 15 | 15 | $2,710 | $608.25 | 22.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 74 | 95 | $1,995 | $478.29 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 53 | $1,643 | $416.47 | 25.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 43 | 46 | $1,564 | $381.34 | 24.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 29 | 43 | $1,376 | $364.67 | 26.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 13 | $533.00 | $210.86 | 39.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 13 | $533.00 | $210.60 | 39.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 15 | $540.00 | $174.90 | 32.4% |
About Cliff Sloop, NP
Cliff Sloop, NP is a Nurse Practitioner healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1548630452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cliff Sloop, NP has received a total of $5,676 in payments from pharmaceutical and medical device companies, with $1,789 received in 2024. These payments were reported across 359 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,576).
As a Medicare-enrolled provider, Sloop has provided services to 11,394 Medicare beneficiaries, totaling 14,040 services with total Medicare billing of $464,914. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Dothan, AL
- Active Since 10/05/2015
- Last Updated 03/03/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1548630452
Products in Payments
- UBRELVY (Drug) $480.55
- TRELEGY ELLIPTA (Drug) $454.99
- QULIPTA (Drug) $299.61
- VRAYLAR (Drug) $285.38
- Kerendia (Drug) $275.38
- MOUNJARO (Drug) $246.73
- JARDIANCE (Drug) $238.87
- XIFAXAN (Drug) $227.06
- NURTEC ODT (Drug) $225.29
- Azstarys (Drug) $188.80
- FREESTYLE LIBRE 2 (Device) $170.68
- FARXIGA (Drug) $166.67
- AIRSUPRA (Drug) $142.72
- XARELTO (Drug) $142.46
- Rybelsus (Drug) $119.65
- Xofluza (Drug) $118.25
- VOQUEZNA (Drug) $108.80
- Vascepa (Drug) $107.68
- TRULICITY (Drug) $106.00
- Tymlos (Drug) $102.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Dothan
Shea Calhoun, Crnp, CRNP
Nurse Practitioner — Payments: $10,938
Christina Bell, N.p.-C, N.P.-C
Nurse Practitioner — Payments: $10,827
Tami Caldwell, Crnp, CRNP
Nurse Practitioner — Payments: $10,206
Mrs. Jennifer Parrish, Crnp, CRNP
Nurse Practitioner — Payments: $9,729
Mrs. Amanda Pybus, Crnp, CRNP
Nurse Practitioner — Payments: $9,641
Mrs. Hollie Crutchfield, Crnp, CRNP
Nurse Practitioner — Payments: $9,568